VIP (etoposide, ifosfamide and cisplatinum) as a salvage intensification program in relapsed or refractory Hodgkin's disease.

Source:http://linkedlifedata.com/resource/pubmed/id/9632268

Download in:

View as

General Info

PMID
9632268